CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
CONMED Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$46.05−0.67 (-1.43%)
Close on Oct 19, 2026
- Market cap
- $1.39B
- P/E (TTM)
- 24.9
- Dividend yield
- 1.30%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
100.0%
34M of 30M shares
Institutional holders
246
44 new, 30 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 2 sales
Net sold $161.09K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 4,679,441 | 15.10% | 13G (passive) amendment | Jun 30, 2025 |
| EARNEST Partners, LLC | 2,784,300 | 9.00% | 13G (passive) amendment | Sep 30, 2024 |
| Vanguard Portfolio Management | 2,120,886 | 6.87% | 13G (passive) | Mar 31, 2026 |
| Fuller & Thaler Asset Management, Inc. | 1,740,630 | 5.63% | 13G (passive) | Jun 30, 2025 |
| Vanguard Capital Management | 1,619,070 | 5.25% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CNMD | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,820,739 | 16.10% | $157.78M | −4,434 | 0.00% |
| Earnest Partners LLC | 2,505,295 | 8.36% | $82.00M | −64,358 | 0.30% |
| Vanguard Portfolio Management LLC | 2,188,761 | 7.31% | $71.64M | +112,344 | 0.00% |
| Fuller & Thaler Asset Management, Inc. | 1,579,917 | 5.27% | $51.71M | −61,849 | 0.14% |
| State Street Corp | 1,417,468 | 4.73% | $46.39M | +33,450 | 0.00% |
| Vanguard Capital Management LLC | 1,355,728 | 4.53% | $44.37M | −28,314 | 0.00% |
| Bank Of America Corp /De/ | 1,341,409 | 4.48% | $43.90M | −61,211 | 0.00% |
| Dimensional Fund Advisors LP | 1,317,370 | 4.40% | $43.12M | −75,550 | 0.01% |
| Sei Investments Co | 988,151 | 3.30% | $32.34M | −16,564 | 0.03% |
| Invenomic Capital Management LP | 842,162 | 2.81% | $27.56M | −92,439 | 1.65% |
| Capital Research Global Investors | 823,636 | 2.75% | $26.96M | −101,812 | 0.00% |
| Geode Capital Management, LLC | 790,138 | 2.64% | $25.87M | +47,531 | 0.00% |
| Two Sigma Investments, LP | 728,976 | 2.43% | $23.86M | −53,564 | 0.02% |
| Allspring Global Investments Holdings, LLC | 618,447 | 2.06% | $20.26M | +35,714 | 0.03% |
| Cooke & Bieler LP | 573,498 | 1.91% | $18.77M | −414,285 | 0.22% |
| Paradigm Capital Management Inc/Ny | 538,245 | 1.80% | $17.62M | New | 0.48% |
| Arrowstreet Capital, Limited Partnership | 476,885 | 1.59% | $15.61M | +57,793 | 0.01% |
| Charles Schwab Investment Management Inc | 471,022 | 1.57% | $15.42M | −7,581 | 0.00% |
| Silvercrest Asset Management Group LLC | 441,361 | 1.47% | $14.45M | −207,216 | 0.09% |
| Goldman Sachs Group Inc | 436,830 | 1.46% | $14.30M | −39,818 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 246 | 34M | 100.0% | 44 / 84 | 82 / 30 | 3M | 3M |
| Q1 2026 | 236 | 34M | 100.0% | 32 / 98 | 74 / 57 | 8M | 6M |
| Q4 2025 | 266 | 36M | 100.0% | 47 / 100 | 94 / 51 | 7M | 5M |
| Q3 2025 | 273 | 35M | 100.0% | 45 / 96 | 99 / 47 | 4M | 5M |
| Q2 2025 | 277 | 35M | 100.0% | 45 / 97 | 95 / 45 | 3M | 3M |
| Q1 2025 | 280 | 36M | 100.0% | 44 / 99 | 96 / 40 | 3M | 3M |
| Q4 2024 | 280 | 36M | 100.0% | 40 / 97 | 98 / 44 | 4M | 2M |
| Q3 2024 | 290 | 34M | 100.0% | 41 / 95 | 110 / 39 | 7M | 4M |
| Q2 2024 | 290 | 36M | 100.0% | 37 / 111 | 108 / 44 | 4M | 5M |
| Q1 2024 | 298 | 37M | 100.0% | 53 / 108 | 106 / 60 | 6M | 6M |
| Q4 2023 | 306 | 38M | 100.0% | 55 / 128 | 90 / 21 | 3M | 1M |
| Q3 2023 | 275 | 36M | 100.0% | 54 / 97 | 90 / 41 | 3M | 2M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of CNMD | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 1,814,383 | 6.06% | $59.38M | 0.05% | Jun 30, 2026 |
| Undiscovered Managers Behavioral Value Fund | 1,319,068 | 4.40% | $43.17M | 0.48% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 958,140 | 3.20% | $31.36M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 806,518 | 2.69% | $26.40M | 0.03% | Jun 30, 2026 |
| SMALLCAP World Fund Inc | 801,295 | 2.68% | $26.23M | 0.03% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 689,876 | 2.30% | $22.58M | 0.01% | Jun 30, 2026 |
| Vanguard Small-Cap Value Index Fund | 437,417 | 1.46% | $14.32M | 0.02% | Jun 30, 2026 |
| Allspring Special Small Cap Value Fund | 434,820 | 1.45% | $14.23M | 0.48% | Jun 30, 2026 |
| Harbor Small Cap Value Fund | 386,410 | 1.29% | $17.89M | 0.71% | Jul 31, 2026 |
| U.S. Small Cap Value Portfolio | 366,995 | 1.23% | $16.99M | 0.09% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 347,139 | 1.16% | $11.36M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 337,280 | 1.13% | $15.62M | 0.05% | Jul 31, 2026 |
| Invenomic Fund | 298,577 | 1.00% | $13.82M | 1.62% | Jul 31, 2026 |
| Small Cap Equity Portfolio | 287,401 | 0.96% | $13.31M | 1.28% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 279,591 | 0.93% | $9.15M | 0.06% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Curt R. Hartman | President and CEO, Director | 93,496 | 0.31% | Nov 8, 2024 |
| John E. Gallagher | Executive Vice President & CFO | 0 | – | Jul 17, 2026 |
| Kimberly Lockwood | Interim Corp Controller & PAO | 1,868 | 0.01% | Jun 3, 2026 |
| Pat Beyer | President & CEO | 10,807 | 0.04% | Apr 2, 2026 |
| Brent Lalomia | Executive VP RA, QA | 1,066 | 0.00% | Mar 18, 2026 |
| Matthew Schabacker | VP GM Advanced Surgical | 0 | – | Mar 18, 2026 |
| Hollie K. Foust | General Counsel & Corp Sec | 2,886 | 0.01% | Mar 18, 2026 |
| Peter K. Shagory | EVP, STRAT & CORP DEVT | 3,897 | 0.01% | Mar 18, 2026 |
| John D. Ferrell | Executive Vice President - HR | 2,402 | 0.01% | Mar 18, 2026 |
| Johonna Marie Pelletier | Treasurer and VP, Tax | 4,634 | 0.02% | Mar 4, 2026 |
| Andrew James Moller | VP Corporate Controller | 0 | – | Mar 4, 2026 |
| Richard Glaze | Chief Information Officer | 0 | – | Nov 24, 2025 |
| Todd W. Garner | Executive Vice President & CFO | 1,836 | 0.01% | Nov 7, 2025 |
| Stephan Epinette | VP GM International | 15,510 | 0.05% | May 15, 2025 |
| Edward A. Clifford | VP Global Manufacturing | 500 | 0.00% | Mar 5, 2025 |
| Kim Kelderman | Director | 500 | 0.00% | Sep 10, 2026 |
| Celine Christine Martin | Director | 0 | – | Jul 2, 2026 |
| Jeffrey B. Mirviss | Director | 0 | – | Jul 2, 2026 |
| Mark Kaye | Director | 820 | 0.00% | Jun 3, 2026 |
| David M. Bronson | Director | 17,909 | 0.06% | Jun 3, 2026 |
| Charles Farkas | Director | 15,527 | 0.05% | Jun 3, 2026 |
| Barbara J. Schwarzentraub | Director | 6,454 | 0.02% | Jun 3, 2026 |
| LaVerne H. Council | Director | 4,716 | 0.02% | Jun 3, 2026 |
| Brian Concannon | Director | 10,116 | 0.03% | Jun 4, 2025 |
| Martha Goldberg Aronson | Director | 14,391 | 0.05% | Jun 4, 2025 |
| John L. Workman | Director | 20,891 | 0.07% | May 21, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Kim Kelderman Director | Sep 8, 2026 | Option exercise | +500 | – | – | 500 |
| Mark Kaye Director | Jun 2, 2026 | Option exercise | +668 | – | – | 820 |
| David M. Bronson Director | Jun 2, 2026 | Option exercise | +668 | – | – | 17,909 |
| Barbara J. Schwarzentraub Director | Jun 2, 2026 | Option exercise | +668 | – | – | 5,012 |
| LaVerne H. Council Director | Jun 2, 2026 | Option exercise | +668 | – | – | 4,716 |
| Charles Farkas Director | Jun 2, 2026 | Option exercise | +668 | – | – | 15,527 |
| Brent Lalomia Executive VP RA, QA | Mar 6, 2026 | Option exercise | +75 | – | – | 941 |
| Brent Lalomia Executive VP RA, QA | Mar 6, 2026 | Tax withholding | −26 | $39.90 | $1.04K | 915 |
| Mark Kaye Director | Feb 24, 2026 | Option exercise | +152 | – | – | 152 |
| Brent Lalomia Executive VP RA, QA | Dec 31, 2025 | Other | +31.63 | $40.60 | $1.28K | 125 |
| Richard Glaze Chief Information Officer | Nov 21, 2025 | Sale(10b5-1 plan) | −257 | $41.21 | $10.59K | 0 |
| Richard Glaze Chief Information Officer | Nov 20, 2025 | Option exercise | +375 | – | – | 375 |
| Richard Glaze Chief Information Officer | Nov 20, 2025 | Tax withholding | −118 | $40.63 | $4.79K | 257 |
| Todd W. Garner Executive Vice President & CFO | Nov 6, 2025 | Sale(10b5-1 plan) | −3,500 | $43.00 | $150.50K | 1,836 |
| Hollie K. Foust General Counsel & Corp Sec | Nov 4, 2025 | Tax withholding | −1,114 | $45.71 | $50.92K | 2,886 |
| Hollie K. Foust General Counsel & Corp Sec | Nov 4, 2025 | Option exercise | +4,000 | – | – | 4,000 |
| Todd W. Garner Executive Vice President & CFO | Oct 31, 2025 | Tax withholding | −2,164 | $44.00 | $95.22K | 5,336 |
| Todd W. Garner Executive Vice President & CFO | Oct 31, 2025 | Option exercise | +7,500 | – | – | 7,500 |
| Charles Farkas Director | Sep 12, 2025 | Sale | −897 | $53.51 | $48.00K | 14,859 |
| Charles Farkas Director | Sep 12, 2025 | Sale | −1,103 | $53.54 | $59.05K | 15,756 |
| Todd W. Garner Executive Vice President & CFO | Aug 7, 2025 | Sale | −598 | $52.45 | $31.37K | 0 |
| LaVerne H. Council Director | Jun 3, 2025 | Option exercise | +479 | – | – | 4,048 |
| Martha Goldberg Aronson Director | Jun 3, 2025 | Option exercise | +479 | – | – | 12,391 |
| David M. Bronson Director | Jun 3, 2025 | Option exercise | +479 | – | – | 17,241 |
| Charles Farkas Director | Jun 3, 2025 | Option exercise | +479 | – | – | 16,859 |
| Brian Concannon Director | Jun 3, 2025 | Option exercise | +479 | – | – | 10,116 |
| Barbara J. Schwarzentraub Director | Jun 3, 2025 | Option exercise | +479 | – | – | 4,344 |
| Charles Farkas Director | May 29, 2025 | Tax withholding | −966 | $57.69 | $55.73K | 16,380 |
| Charles Farkas Director | May 29, 2025 | Option exercise | +1,000 | $55.70 | $55.70K | 17,346 |
| John L. Workman Director | May 20, 2025 | Option exercise | +479 | $59.84 | $28.66K | 20,891 |
| Charles Farkas Director | May 5, 2025 | Sale | −4,000 | $56.94 | $227.76K | 16,346 |
| Todd W. Garner Executive Vice President & CFO | Mar 31, 2025 | Award | +371 | $57.37 | $21.28K | 598 |
| Peter K. Shagory EVP, STRAT & CORP DEVT | Mar 14, 2025 | Tax withholding | −4,316 | $58.83 | $253.91K | 3,897 |
| Peter K. Shagory EVP, STRAT & CORP DEVT | Mar 14, 2025 | Option exercise | +4,500 | $55.42 | $249.39K | 8,213 |
| Brent Lalomia Vice President QA and RA | Mar 7, 2025 | Option exercise | +75 | – | – | 1,032 |
| Brent Lalomia Vice President QA and RA | Mar 7, 2025 | Tax withholding | −26 | $62.74 | $1.63K | 1,006 |
| Richard Glaze Chief Information Officer | Feb 11, 2025 | Sale | −257 | $65.35 | $16.79K | 0 |
| Brent Lalomia Executive VP RA, QA | Dec 31, 2024 | Other | +22.99 | $68.44 | $1.57K | 94 |
| Richard Glaze Chief Information Officer | Nov 20, 2024 | Tax withholding | −118 | $70.69 | $8.34K | 257 |
| Richard Glaze Chief Information Officer | Nov 20, 2024 | Option exercise | +375 | – | – | 375 |
| Curt R. Hartman President and CEO, Director | Nov 7, 2024 | Tax withholding | −24,303 | $74.76 | $1.82M | 9,996 |
| Curt R. Hartman President and CEO, Director | Nov 7, 2024 | Option exercise | +30,000 | $51.30 | $1.54M | 34,299 |
| Charles Farkas Director | Sep 5, 2024 | Option exercise | +1,000 | $39.64 | $39.64K | 20,880 |
| Charles Farkas Director | Sep 5, 2024 | Tax withholding | −534 | $74.31 | $39.68K | 20,346 |
| Edward A. Clifford VP Global Manufacturing | Aug 1, 2024 | Option exercise | +500 | – | – | 500 |
| Edward A. Clifford VP Global Manufacturing | Aug 1, 2024 | Tax withholding | −122 | $65.34 | $7.97K | 378 |
| Stanley W. Peters III President AS and AET | Jun 14, 2024 | Option exercise | +4,000 | $41.93 | $167.72K | 4,063 |
| Stanley W. Peters III President AS and AET | Jun 14, 2024 | Sale | −4,000 | $71.82 | $287.28K | 63 |
| Brian Concannon Director | May 31, 2024 | Option exercise | +302 | – | – | 9,637 |
| Barbara J. Schwarzentraub Director | May 31, 2024 | Option exercise | +302 | – | – | 3,865 |
| Charles Farkas Director | May 31, 2024 | Option exercise | +302 | – | – | 19,880 |
| David M. Bronson Director | May 31, 2024 | Option exercise | +302 | – | – | 16,762 |
| Jerome J. Lande Director | May 31, 2024 | Option exercise | +302 | – | – | 3,856 |
| John L. Workman Director | May 31, 2024 | Option exercise | +302 | – | – | 20,412 |
| Martha Goldberg Aronson Director | May 31, 2024 | Option exercise | +302 | – | – | 11,912 |
| LaVerne H. Council Director | May 31, 2024 | Option exercise | +302 | – | – | 3,569 |
| David M. Bronson Director | May 13, 2024 | Buy | +1,350 | $72.09 | $97.32K | 16,460 |
| Barbara J. Schwarzentraub Director | May 8, 2024 | Buy | +1,442 | $69.26 | $99.87K | 1,442 |
| Martha Goldberg Aronson Director | May 6, 2024 | Buy | +2,000 | $70.98 | $141.96K | 2,000 |
| Pat Beyer Chief Operating Officer | Apr 30, 2024 | Buy | +3,000 | $68.30 | $204.90K | 10,807 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Richard Glaze Officer | Nov 21, 2025 | 257 | $10.59K | Nov 21, 2025 | Restricted Stock Vesting |
| Todd W. Garner Officer | Nov 6, 2025 | 3,500 | $150.50K | Nov 6, 2025 | Restricted Stock Vesting |
| Charles Farkas Director | Sep 12, 2025 | 2,000 | $107.05K | Sep 12, 2025 | Restricted Stock Vesting |
| Todd W. Garner Officer | Aug 7, 2025 | 598 | $31.37K | Aug 7, 2025 | ESPP Purchase |
| Charles Farkas Director | May 5, 2025 | 4,000 | $227.77K | May 5, 2025 | Restricted Stock Vesting |
| Curt R. Hartman Former Officer | Feb 14, 2025 | 2,905 | $188.51K | Feb 14, 2025 | Stock Appreciation Rights |
| Curt R. Hartman Former Officer | Feb 13, 2025 | 4,986 | $313.87K | Feb 13, 2025 | Stock Appreciation Rights |
| Richard Glaze Officer | Feb 11, 2025 | 257 | $16.80K | Feb 11, 2025 | Restricted Stock Vesting |
| Curt R. Hartman Officer, Director | Nov 8, 2024 | 2,849 | $213.22K | Nov 8, 2024 | Stock Appreciation Rights |
| Stanley W. Peters III Officer | Aug 27, 2024 | 2,171 | $157.18K | Aug 27, 2024 | Stock Appreciation Rights |
| Stanley W. Peters III Officer | Jun 14, 2024 | 4,000 | $287.28K | Jun 14, 2024 | Option Granted - 03/01/2017 |
| Stanley W. Peters III Officer | Dec 4, 2023 | 2,300 | $252.83K | Dec 4, 2023 | Option Granted 03/01/2017 |
| Stanley W. Peters III Officer | Nov 7, 2023 | 1,200 | $122.87K | Nov 7, 2023 | Option Granted - 03/01/2017 |
| Stanley W. Peters III Officer | Sep 13, 2023 | 2,000 | $214.63K | Sep 13, 2023 | Option Granted - 03/01/2017 |
| Todd W. Garner Officer | Aug 16, 2023 | 1,355 | $151.76K | Aug 16, 2023 | ESPP Purchase |